Wells Fargo lowered the firm’s price target on Clorox (CLX) to $117 from $125 and keeps an Equal Weight rating on the shares. The firm notes the company’s Q1 and FY26 guide were soft albeit amid fears that had built. Wells doesn’t expect much change to narrative here, awaiting needed improvement into the second half of the year and debates on underlying growth into FY27.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
